1. TRIM25 activates Wnt/β-catenin signalling by destabilising MAT2A mRNA to drive thoracic aortic aneurysm development.
- Author
-
Li C, Wang K, Fang J, Qin L, Ling Q, and Yu Y
- Subjects
- Animals, Mice, Myocytes, Smooth Muscle metabolism, Apoptosis genetics, beta Catenin metabolism, beta Catenin genetics, Humans, Transcription Factors genetics, Transcription Factors metabolism, Tripartite Motif Proteins genetics, Tripartite Motif Proteins metabolism, Disease Models, Animal, Male, RNA, Messenger genetics, RNA, Messenger metabolism, Angiotensin II pharmacology, Aortic Aneurysm, Thoracic genetics, Aortic Aneurysm, Thoracic metabolism, Aortic Aneurysm, Thoracic pathology, Wnt Signaling Pathway genetics, Muscle, Smooth, Vascular metabolism, Muscle, Smooth, Vascular pathology, Methionine Adenosyltransferase genetics, Methionine Adenosyltransferase metabolism
- Abstract
This study explored the roles of methionine adenosyltransferase 2A (MAT2A) and tripartite motif containing 25 (TRIM25) in the progression of thoracic aortic aneurysm (TAA). The TAA model was established based on the β-aminopropionitrile method. The effects of MAT2A on thoracic aortic lesions and molecular levels were analyzed by several pathological staining assays (hematoxylin-eosin, Verhoeff-Van Gieson, TUNEL) and molecular biology experiments (qRT-PCR, Western blot). Angiotensin II (Ang-II) was used to induce injury in vascular smooth muscle cells (VSMCs) in vitro. The effects of MAT2A, shMAT2A, shTRIM25 and/or Wnt inhibitor (IWR-1) on the viability, apoptosis and protein expressions of VSMCs were examined by CCK-8, Annexin V-FITC/PI and Western blot assays. In TAA mice, overexpression of MAT2A alleviated thoracic aortic injury, inhibited the aberrant expressions of aortic contractile proteins and dedifferentiation markers, and blocked the activation of Wnt/β-catenin pathway. In Ang-II-induced VSMCs, up-regulation of MAT2A increased cellular activity and repressed the expression of β-catenin protein. TRIM25 knockdown promoted activity of VSMCs, inhibited apoptosis, and blocked the Wnt/β-catenin pathway activation by binding to MAT2A. IWR-1 partially counteracted the regulatory effects of shMAT2A. Collectively, TRIM25 destabilises the mRNA of MAT2A to activate Wnt/β-catenin signaling and ultimately exacerbate TAA injury., (© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF